Bone morphogenetic protein-7 delays podocyte injury due to high glucose

Nephrology Dialysis Transplantation

Volumn 22, Issue 12, 2007, Pages 3442-3450

  De Petris, Laura ^a   Hruska, Keith A ^a,b   Chiechio, Santina ^b   Liapis, Helen ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMP 7; High glucose; Human; Laser capture microdissection; Mouse; Podocyte

Indexed keywords

GLUCOSE; MESSENGER RNA; OSTEOGENIC PROTEIN 1; PODOCIN; RECOMBINANT OSTEOGENIC PROTEIN 1; STRUCTURAL PROTEIN; SYNAPTOPODIN;

ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL IMMORTALIZATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXCISION; FEMALE; GLOMERULUS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LASER CAPTURE MICRODISSECTION; MALE; MOUSE; NONHUMAN; PARALLEL DESIGN; PODOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ADULT; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE; DIABETIC NEPHROPATHIES; FEMALE; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MIDDLE AGED; PODOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 36749101547     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm503     Document Type: Article

References (42)

1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787
2. Marshall SM. The podocyte: a major player in the development of diabetic nephropathy? Horm Metab Res 2005; 37: 9-16
3. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999; 56: 393-405
4. Susztak K, Raff AC, Schiffer M et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225-233
5. Nakamura T, Ushiyama C, Suzuki S et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000; 15: 1379-1383
6. Srivastava T, Garola RE, Whiting JM et al. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 2001; 59: 118-125
7. Asanuma K, Yanagida-Asanuma E, Faul C et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol 2006; 8: 485-491
8. Gerke P, Sellin L, Kretz O et al. NEPH2 is located at the glomerular slit diaphragm, interacts with nephrin and is cleaved from podocytes by metalloproteinases. J Am Soc Nephrol 2005; 16: 1693-1702
9. Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003; 14: 2958-2966
10. Wang S, Denichilo M, Brubaker C et al. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 2001; 60: 96-105
11. Yang C, Vlassara H, Peten EP et al. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci 1994; 91: 9436-9440
12. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995; 44: 1139-1146
13. Lyons KM, Hogan BL, Robertson EJ. Colocalization of BMP 7 and BMP 2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech Dev 1995; 50: 71-83
14. Gould SE, Day M, Jones S et al. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 2002; 61: 51-60
15. Hruska KA, De Petris L, Li T, et al. Contemporary diabetes: the diabetic kidney. Edited by P Cortes and CE Mogensen. The Prospect of a Novel Therapeutic, BMP7, in Diabetic Nephropathy. Chapter 18, Humana Press, Totowa, NJ. 2006
16. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 2001; 12: 2392-2399
17. Wang S, Chen Q, Simon TC et al. Bone morphogenetic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 2003; 63: 2037-2049
18. Abbate M, Zoja C, Morigi M et al. Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am J Pathol 2002; 161: 2179-2193
19. Wang S, de Caestecker M, Kopp J et al. Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 2006; 17: 2504-2512
20. Mundel P, Reiser J, Zúñiga Mejía Borja A et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258
21. Jain S, Suarez AA, McGuire J, Liapis H. Expression profiles of congenital renal dysplasia reveal new insights in renal development and disease. Ped Nephrol 2007; 22: 962-974
22. Tiniakos DG, Yu H, Liapis H. Osteopontin expression in ovarian carcinomas and tumors of low malignant potential (LMP). Hum Pathol 1998; 29: 1250-1254
23. Ceol M, Del Prete D, Tosetto E. GAPDH as housekeeping gene at renal level. Kidney Int 2004; 65: 1972-1973; author reply 1973-1974
24. Dai T, Natarajan R, Nast C et al. Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. Kidney Int 2006; 69: 806-814
25. Kim YH, Goyal M, Kurnit D et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60: 957-968
26. Steffes MW, Schmidt D, McCrery R et al. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001; 59: 2104-2113
27. Murata I, Takemura G, Asano K et al. Apoptotic cell loss following cell proliferation in renal glomeruli of Otsuka Long-Evans Tokushima fatty rats, a model of human type 2 diabetes. Am J Nephrol 2002; 22: 587-595
28. Kumar D, Robertson S, Burns KD. Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem 2004; 259: 67-70
29. Petermann AT, Pippin J, Krofft R et al. Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis. Nephron Exp Nephrol 2004; 98: 114-123
30. Pagtalunan ME, Miller PL, Jumping-Eagle S. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342-348
31. Barisoni L, Bruggeman LA, Mundel P et al. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 2000; 58: 173-181
32. Pollak MR. The genetic basis of FSGS and steroid-resistant nephrosis. Seminars Nephrol 2003; 23: 141-146
33. Bariety J, Nochy D, Mandet C et al. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998; 53: 918-925
34. Huber TB, Simons M, Hartleben B et al. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 2003; 12: 3397-3405
35. Ransom. Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction. FASEB J 2002; 16: 315-326
36. De Petris L, Jain S, Hruska K, Liapis H. Podocyte gene expression profiling in an in vitro model of diabetic nephropathy. Modern Path 2006; 19: 1209A
37. Kojma Y, Hirata K, Ishida T et al. Endothelial lipase modulates monocyte adhesion to the vessel wall. A potential role in inflammation. J Biol Chem 2004; 279: 54032-54038
38. Broedl UC, Jin W, Marchadier D et al. Expression pattern of human endothelial lipase in transgenic mice. Atherosclerosis 2005; 181: 271-274
39. Makino H, Miyamoto Y, Sawai K et al. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 2006; 55: 2747-2756
40. Morrissey J, Hruska K, Guo G et al. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002; 13: S14-S21
41. Simon M, Maresh JG, Harris SE et al. Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol 1999; 276: F382-F389
42. Zeisberg M, Bottiglio C, Kumar N et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Phys (Renal) 2003; 285: 1060-1067